This may be due to the limited availability of T-cell markers, which resulted in misclassification as UCT, including both patients that are ALK-positive and ALK-negative, represented 23% of T-cell lymphomas, higher than the 13.1% reported in previous Asian research patients that are ALK-positive were slightly more common, consistent with previous reports indicating a better prognosis for patients that are ALK-positive.35-37. The gene discussed is ALK; the disease is T-cell non-Hodgkin lymphoma.